ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL)

Historical Holders from Q4 2015 to Q3 2025

Symbol
AVXL on Nasdaq
Type / Class
Equity / COM NEW
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
32,414,745
Holdings value
$288,983,896
% of all portfolios
0%
Number of holders
182
Number of buys
80
Number of sells
-67
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 32,414,745 $288,983,896 -$271,918 $8.9 182
2025 Q2 32,493,276 $301,726,227 +$10,099,072 $9.22 175
2025 Q1 31,369,737 $269,176,281 +$13,007,767 $8.58 178
2024 Q4 29,517,793 $315,846,815 +$29,159,103 $10.74 167
2024 Q3 26,968,911 $153,149,145 -$533,008 $5.68 143
2024 Q2 26,760,101 $112,930,774 -$18,727,572 $4.22 141
2024 Q1 30,926,232 $157,393,367 +$27,972,376 $5.09 145
2023 Q4 107,561 $1,006,613 -$128,134 $9.31 3
2023 Q3 24,759,938 $162,169,378 -$1,915,419 $6.55 136
2023 Q2 25,006,639 $203,407,463 -$13,951,764 $8.13 141
2023 Q1 26,821,822 $229,820,001 +$901,446 $8.57 136
2022 Q4 26,708,994 $247,353,216 +$23,129,346 $9.26 132
2022 Q3 24,328,020 $251,022,226 -$6,427,620 $10.32 137
2022 Q2 24,855,055 $248,828,941 -$1,786,812 $10.01 139
2022 Q1 24,881,145 $306,327,437 +$35,668,129 $12.31 128
2021 Q4 21,730,193 $376,713,229 +$23,082,130 $17.34 140
2021 Q3 20,602,940 $369,956,693 -$25,099,352 $17.95 131
2021 Q2 21,526,144 $492,157,598 +$83,641,389 $22.86 121
2021 Q1 17,922,177 $267,835,028 +$76,824,552 $14.95 97
2020 Q4 13,888,252 $74,995,896 +$6,360,567 $5.4 84
2020 Q3 12,654,648 $57,561,265 +$3,917,492 $4.55 72
2020 Q2 11,933,727 $58,779,085 +$1,913,567 $4.92 72
2020 Q1 9,230,313 $29,070,371 -$5,095,949 $3.15 61
2019 Q4 13,899,170 $36,000,820 +$1,470,418 $2.59 55
2019 Q3 13,275,120 $41,949,608 +$4,794,773 $3.16 52
2019 Q2 11,766,555 $39,648,052 +$14,871,615 $3.37 53
2019 Q1 7,377,419 $22,500,282 +$2,213,560 $3.05 50
2018 Q4 6,715,415 $10,473,190 -$2,650,297 $1.56 44
2018 Q3 8,213,369 $22,311,576 -$2,310,404 $2.73 44
2018 Q2 9,088,737 $23,812,662 -$3,161,271 $2.62 52
2018 Q1 10,279,544 $28,366,015 +$329,454 $2.76 53
2017 Q4 10,136,311 $32,637,077 +$291,374 $3.22 57
2017 Q3 10,032,704 $41,530,671 -$992,956 $4.14 59
2017 Q2 10,289,280 $54,731,640 +$4,827,566 $5.32 55
2017 Q1 9,371,190 $53,788,000 +$19,417,210 $5.74 53
2016 Q4 7,504,805 $29,715,887 +$11,504,655 $3.96 57
2016 Q3 4,581,849 $16,626,382 +$2,563,093 $3.63 50
2016 Q2 3,826,280 $23,378,725 +$10,539,974 $6.11 44
2016 Q1 2,161,346 $10,589,000 +$3,771,911 $4.9 39
2015 Q4 1,368,718 $7,623,000 +$7,619,984 $5.57 25